Paion AG | Income Statement

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
4,227.80
3,455.80
71.60
4,261.80
5,811.20
2,765.90
Cost of Goods Sold (COGS) incl. D&A
304.40
316.00
356.70
324.00
246.10
236
Gross Income
3,923.40
3,139.90
285.10
3,937.80
5,565.10
2,529.90
SG&A Expense
7,593.30
15,189.40
34,768.00
28,213.00
21,435.00
15,338.90
EBIT
3,490.90
12,049.60
35,053.10
24,275.20
15,869.90
12,809.10
Unusual Expense
354.00
-
-
-
-
-
Non Operating Income/Expense
324.30
410.70
965.10
806.90
2.40
353.80
Interest Expense
223.00
-
-
-
-
-
Pretax Income
2,980.10
11,573.10
34,046.30
25,061.20
15,852.40
12,449.10
Income Tax
768.10
2,468.30
5,834.00
4,943.60
3,759.00
2,509.70
Consolidated Net Income
2,212.00
9,104.80
28,212.40
20,117.60
12,093.40
9,939.40
Net Income
2,212.00
9,104.80
28,212.40
20,117.60
12,093.40
9,939.40
Net Income After Extraordinaries
2,212.00
9,104.80
28,212.40
20,117.60
12,093.40
9,939.40
Net Income Available to Common
2,212.00
9,104.80
28,212.40
20,117.60
12,093.40
9,939.40
EPS (Basic)
0.08
0.23
0.56
0.38
0.21
0.16
Basic Shares Outstanding
28,490.80
40,209.50
51,069.80
53,684.20
59,118.70
62,512.40
EPS (Diluted)
0.08
0.22
0.55
0.37
0.20
0.16
Diluted Shares Outstanding
28,490.80
40,678.50
51,314.80
53,932.40
59,118.70
62,512.40
EBITDA
3,186.50
11,737.80
34,707.40
23,951.20
15,623.80
12,573
Other Operating Expense
179.00
-
-
-
-
-
Non-Operating Interest Income
55.40
65.80
41.70
20.90
19.80
6.20

About Paion

View Profile
Address
Martinstraße 10-12
Aachen Nordrhein-Westfalen 52062
Germany
Employees -
Website http://paion.com
Updated 07/08/2019
PAION AG is a pharmaceutical company. It engages in developing drugs to be used in out-patient and hospital-based sedation, anesthesia and critical care services. The company also provides management and other services.